The US Department of Agriculture Food Safety and Inspection Service (USDA-FSIS) has announced details of their sampling program for cell-cultured meat and poultry products.
Read MoreA new USDA directive establishes inspection requirements for companies producing cultured meat which will be jointly overseen by the FDA and FSIS. Products will be subject to the same FSIS regulatory requirements and oversight authority as meat and poultry products derived from animal slaughter, but labels applied to these foods are not eligible for generic approval.
Read MoreA USDA advanced notice of proposed rulemaking (ANPRM) is seeking public comment on amending and clarifying regulatory jurisdiction over genetically engineered agricultural animals.
Read MoreIn a joint webinar released on July 24th, 2020, representatives from the US Food and Drug Administration (FDA) and Department of Agriculture (USDA) presented the current framework for “Regulatory Oversight of Cultured Animal Cell Human and Animal Food Products”.
Read MoreThe U.S. Department of Agriculture (USDA) recently announced a new guide for research and funding in animal genomics for 2018-2027.
Read MoreFollowing a two-year comment period, USDA has released a final ruling on labeling requirements for bioengineered foods.
Read MoreThe proposed new rule would require food manufacturers and other entities that label foods for retail sale to disclose if the product contains bioengineered food, or food ingredients.
Read MoreIn this post, we update our knowledge on inhalation of cellulose nanocrystal (CNC) and cellulose nano/micro fibril (CNF/CMF) dusts and discuss best practices for working safely with them.
Read MoreTheNational Academies of Science, Engineering, and Medicine (NAS) were asked to form a committee in response to the order from the Executive Office of President in July 2015, in which the EPA, FDA, and USDA were charged with the responsibility of analyzing "the future of biotechnologies in regards to potential new risks and frameworks for risk assessment and areas in which risks or lack of risks relating to the products of biotechnology are well understood."
Read MoreThe National Strategy for Modernizing the Regulatory System for Biotechnology Products (Strategy), was published in September of 2016 along with the 2017 Update to the Coordinated Framework (see our previous post).
Read More